Cord Blood Stem Cells
Stem cells were first identified in cord blood over 40 years ago. Since then cord blood has been used routinely for hematopoietic stem cell transplantation. Cord blood contains a mixed population of cells, including hematopoietic stem cells (HSC) and mesenchymal stems cells (MSC). These cells have the capacity to self-renew, release growth factors, and further develop into more specialized cells. These cells have also been associated with contributing to tissue homeostasis, reducing inflammation and having antioxidant properties.
(Umbilical) Cord Blood Stem Cells are minimally manipulated human stem cells derived from umbilical cord blood. A proprietary process is used to preserve the tissue characteristics and properties.
Benefits of Cord Blood Stem Cells.
Umbilical cord blood stem cells are more aptly suited to boosting the patient’s own immune system and helping a patient recover after surgery or illness. The healing qualities of cord blood work best when applied to the patient during the healing and recovery process. Boosting the patient’s overall immune system is best achieved with a specialized protocol using cord blood stem cell
Quality & Custody
We take control and custody of the umbilical cord moments after a healthy baby is born. We then transport, process, cryofreeze and deliver the finished cell product directly to local medical professionals that we know and trust. At no point do we permit third parties to take control of our product. Over the years we have found this to the best way to assure to our patients that they are getting the absolute best stem cell product available. We do not purchase umbilical cords from brokers, nor do we ship our cellular products to distributors.
All umbilical cord donors are pre-screened and undergo rigorous and comprehensive testing that includes:
- Behavioral risk assessment
- Physical assessment
- Donor medical history
- Communicable disease testing
Infectious disease testing is performed at certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.